Two months after Athira Pharma placed Chief Executive Officer Leen Kawas on temporary leave, the company has appointed new execs to its team. It is also rigorously advancing clinical-stage development of a compound in Alzheimer’s and Parkinson’s disease dementia.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,